Entera Bio Ltd. — Investor Relations & Filings
Entera Bio Ltd. is a clinical-stage company developing orally delivered peptide and protein replacement therapies. The company leverages its proprietary N-Tab™ technology platform, which is designed to stabilize peptides in the gastrointestinal tract and promote their absorption into the bloodstream, offering a tablet-based alternative to injections. Its development pipeline targets significant unmet medical needs. Key programs include EB613, an oral teriparatide (PTH(1-34)) for postmenopausal women with high-risk osteoporosis, and EB612 for patients with hypoparathyroidism. Other programs include an oral oxyntomodulin for obesity and an oral GLP-2 peptide for rare malabsorption conditions such as short bowel syndrome.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 424B3 | 2026-05-15 | English | |
| 10-Q - Entera Bio Ltd. (0001638097) (Filer) | 2026-05-08 | English | |
| Stromnetz unter Druck, Milliarden flieen und ein kaum bekannter Micro-Cap konnte profitieren (OTCQB: DUKRD) | 2026-03-25 | German | |
| 8-K - ENTERA BIO LTD. (0001638097) (Filer) | 2026-03-04 | English | |
| 4 Filing | 2026-02-17 | English | |
| 4 Filing | 2026-02-11 | English |
Browse filings by year
11 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46362385 | 424B3 | 2026-05-15 | English | ||
| 44402003 | 10-Q - Entera Bio Ltd. (0001638097) (Filer) | 2026-05-08 | English | ||
| 33041488 | Stromnetz unter Druck, Milliarden flieen und ein kaum bekannter Micro-Cap konnte profitieren (OTCQB: DUKRD) | 2026-03-25 | German | ||
| 32895639 | 8-K - ENTERA BIO LTD. (0001638097) (Filer) | 2026-03-04 | English | ||
| 31050014 | 4 Filing | 2026-02-17 | English | ||
| 31050049 | 4 Filing | 2026-02-11 | English | ||
| 31050011 | 4 Filing | 2026-02-11 | English | ||
| 31049947 | 4 Filing | 2026-02-11 | English | ||
| 31049842 | 4 Filing | 2026-02-11 | English | ||
| 31050089 | 3 Filing | 2026-02-09 | English | ||
| 31049909 | 8-K Filing | 2026-02-09 | English | ||
| 31049905 | 3 Filing | 2026-02-05 | English | ||
| 31049870 | 8-K Filing | 2026-02-04 | English | ||
| 12863475 | Director's Dealing 2026 | 2026-01-02 | English | ||
| 12863477 | Director's Dealing 2026 | 2026-01-02 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Ajanta Pharma Ltd.
Specialty pharmaceutical firm focused on complex generics a…
|
AJANTPHARM | IN | Manufacturing |
|
Akari Therapeutics Plc
Develops next-gen antibody-drug conjugates using proprietar…
|
AKTX | US | Manufacturing |
|
Akebia Therapeutics, Inc.
A biopharmaceutical company that develops and commercialize…
|
AKBA | US | Manufacturing |
|
Akeso, Inc.
Global commercial-stage biopharma developing innovative ant…
|
9926 | KY | Manufacturing |
|
Aktis Oncology, Inc.
A clinical-stage biotech developing targeted alpha radiopha…
|
AKTS | US | Manufacturing |
|
Akums Drugs and Pharmaceuticals Limited
CDMO providing end-to-end pharmaceutical manufacturing and …
|
AKUMS | IN | Manufacturing |
|
Albert David Ltd.
Produces pharmaceutical formulations, infusions, and specia…
|
ALBERTDAVD | IN | Manufacturing |
|
Aldeyra Therapeutics, Inc.
Develops medications for immune-mediated ocular and systemi…
|
ALDX | US | Manufacturing |
|
Aleafia Health Inc.
Vertically integrated cannabis company with cultivation, pr…
|
AH | CA | Manufacturing |
|
Alector, Inc.
Clinical-stage biotech using immuno-neurology to treat neur…
|
ALEC | US | Manufacturing |
Entera Bio Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35604/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35604 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35604 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35604 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35604}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Entera Bio Ltd. (id: 35604)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.